Listed

Argenx SE: Form 20-F for the period ended Dec 31, 2021

Filed with the SEC on Mar 21, 2022 and accepted by EDGAR at Mar 21, 2022, 16:56 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2021-01-01 to 2021-12-31$497.3mifrs-full:RevenueFromContractsWithCustomers
Operating income12 months2021-01-01 to 2021-12-31−$348.7mifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2021-01-01 to 2021-12-31$8.5mifrs-full:IncomeTaxExpenseContinuingOperations
Diluted EPS12 months2021-01-01 to 2021-12-31−$7.99ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2021-01-01 to 2021-12-31−$7.99ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2021-01-01 to 2021-12-31−$606.8mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2021-01-01 to 2021-12-31$3.6mifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2021-12-31$1.33bnifrs-full:CashAndCashEquivalents
Current assetsAt period end2021-12-31$2.54bnifrs-full:CurrentAssets
Total assetsAt period end2021-12-31$2.85bnifrs-full:Assets
Current liabilitiesAt period end2021-12-31$301.2mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2021-12-31$316.1mifrs-full:Liabilities
Shareholders' equityAt period end2021-12-31$2.53bnifrs-full:Equity
Shares outstandingAt period end2021-12-3151,668,315 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001558370-22-003983. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.